NEW YORK ( TheStreet) -- CHANGE IN RATINGS Applied Industrial ( AIT was downgraded at Wunderlich to hold from buy. Valuation call, based on a $56 price target, Wunderlich said. Broadcom ( BRCM was downgraded at UBS to neutral from buy. Connectivity headline risk, said UBS. Price target goes to $30. BRE Properties ( BRE was downgraded at UBS to neutral from buy. The sale to Land & Buildings is unlikely, said UBS. Price target goes to $55. Citrix Systems ( CTXS - Get Report) was upgraded at Credit Suisse to outperform from neutral. XenMobile and the partnership with Cisco are expected to reaccelerate growth, Credit Suisse said. Cubic ( CUB was upgraded at Benchmark to buy from hold. $60 price target. The defense backlog is improving in a challenging environment, Benchmark said. EA - Get Report) was initiated with a buy rating and $30.83 price target at Benchmark. Battlefield 4 can drive near-term growth, Benchmark said. Garmin ( GRMN was upgraded to buy at TheStreet Ratings. HSN ( HSNI was upgraded at Wunderlich to buy from hold. $75 price target. Company has competitive advantages, especially in mobile, Wunderlich said. ITT ( ITT was upgraded at FBR Capital Markets to market perform from underperform. $32 price target. The outlook is improving in Europe, and investors are favoring industrial names, FBR Capital Markets said. LGND was downgraded at Cantor Fitzgerald to sell from hold. The loss of two late-stage clinical programs outweighs second-quarter 2013 performance. Price target is $37. Linear Technology ( LLTC was downgraded at UBS to neutral from buy. Valuation and slowing wireless growth, said UBS. Price target is $40. LinkedIn ( LNKD was upgraded at Cantor Fitzgerald to buy from hold. $250 price target. Long-term outlook continues to improve, Cantor Fitzgerald said. Mosaic ( MOS was downgraded at UBS to neutral from buy. Reflects breakdown of a potash cartel, said UBS. Price target goes to $40. Mylan ( MYL was upgraded at Morgan Stanley to overweight from equal-weight. Price target is $41. Management has outlined key future growth opportunities, and the current valuation is attractive, Morgan Stanley said. Mylan was downgraded at Needham to buy from strong buy. Valuation call, based on a $40 price target, Needham said.
Taminco ( TAM was downgraded at UBS to neutral from buy. Based on valuation, said UBS. Price target goes to $24, UBS said. United Stationers ( USTR was downgraded at Wunderlich to hold from buy. $42 price target. Gross margin may be peaking, Wunderlich said. VCLK was downgraded at Needham to hold from buy. Media revenue growth is slowing down, Needham said. Viropharma ( VPHM was downgraded at Leerink Swann to market perform from outperform. Price target is $34. Benefits of the new pipeline have been priced into the stock, Leerink Swann said. Validus Holdings ( VR was downgraded to hold at TheStreet Ratings.